Kliknij ten link, aby zobaczyć inne rodzaje publikacji na ten temat: Combined modality.

Artykuły w czasopismach na temat „Combined modality”

Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych

Wybierz rodzaj źródła:

Sprawdź 50 najlepszych artykułów w czasopismach naukowych na temat „Combined modality”.

Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.

Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.

Przeglądaj artykuły w czasopismach z różnych dziedzin i twórz odpowiednie bibliografie.

1

McGinn, Cornelius J., and Timothy J. Kinsella. "Combined modality therapy." Current Opinion in Oncology 3, no. 6 (1991): 1049–54. http://dx.doi.org/10.1097/00001622-199112000-00013.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

Burke, Patricia A., Sally J. DeNardo, Laird A. Miers, David L. Kukis, and Gerald L. DeNardo. "Combined modality radioimmunotherapy." Cancer 94, S4 (2002): 1320–31. http://dx.doi.org/10.1002/cncr.10303.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

Aisner, Joseph. "Update in Combined Modality." Chest 89, no. 4 (1986): 303S—305S. http://dx.doi.org/10.1378/chest.89.4_supplement.303s.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

Kalsotra, Gopika. "Rhinocerebral Mycosis: Combined Modality Protocol." An International Journal of Otorhinolaryngology Clinics 1, no. 1 (2009): 49–54. http://dx.doi.org/10.5005/jp-journals-10003-1007.

Pełny tekst źródła
Streszczenie:
Abstract Rhinocerebral mycosis is an invasive fungal infection which occurs primarily in the paranasal sinuses and progresses to involve the brain and/or the orbit. It is commonly seen in immunocompromised individuals and can be most effectively treated if diagnosed early, when it is limited to the nasal cavity and the paranasal sinuses. Even though it is acceptable that surgical debridement in combination with antifungal therapy can lead to high rate of cure, the surgical approach for intracranial extension is still a subject of debate. Twenty-four cases of rhinocerebral mycosis managed at ou
Style APA, Harvard, Vancouver, ISO itp.
5

Renner, Ian G., Patricia S. Gordon, Lori R. Rezabek-Kells, Mimi Chang, and Kristina K. Neagos. "Combined modality treatment in cholangiocarcinoma." American Journal of Gastroenterology 95, no. 9 (2000): 2485. http://dx.doi.org/10.1111/j.1572-0241.2000.02611.x.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

Rosenberg, Steven A. "Combined-Modality Therapy of Cancer." New England Journal of Medicine 312, no. 23 (1985): 1512–14. http://dx.doi.org/10.1056/nejm198506063122309.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

Giaccone, G. "Pleural mesothelioma: combined modality treatments." Annals of Oncology 13 (October 2002): 217–25. http://dx.doi.org/10.1093/annonc/mdf663.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
8

McLean, J. Nicolas, Sunjay R. Nunley, Carmen Klass, Charles Moore, Müller Susan, and A. S. Johnstone Peter. "Combined modality therapy of esthesioneuroblastoma." Otolaryngology–Head and Neck Surgery 136, no. 6 (2007): 998–1002. http://dx.doi.org/10.1016/j.otohns.2006.11.051.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

Fuller, Donald B., and John S. Chambers. "Superior sulcus tumors: Combined modality." Annals of Thoracic Surgery 57, no. 5 (1994): 1133–39. http://dx.doi.org/10.1016/0003-4975(94)91343-9.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
10

Juergens, Rosalyn A., and Arlene Forastiere. "Combined Modality Therapy of Esophageal Cancer." Journal of the National Comprehensive Cancer Network 6, no. 9 (2008): 851–61. http://dx.doi.org/10.6004/jnccn.2008.0063.

Pełny tekst źródła
Streszczenie:
Esophageal cancer is a deadly disease. Only one third of patients with localized disease experience long-term survival. Over the past 20 years, investigators have evaluated neoadjuvant strategies to improve the outcomes of surgical management. Chemotherapy and radiation have been evaluated individually and in combination for preoperative management of patients with localized esophageal cancer. This article provides a critical review of the data on multimodality approaches to the management of esophageal cancer.
Style APA, Harvard, Vancouver, ISO itp.
11

Mierzwa, Michelle L., Mukesh K. Nyati, Meredith A. Morgan, and Theodore S. Lawrence. "Recent Advances in Combined Modality Therapy." Oncologist 15, no. 4 (2010): 372–81. http://dx.doi.org/10.1634/theoncologist.2009-s105.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
12

&NA;. "Combined modality therapy for pancreatic cancer." Inpharma Weekly &NA;, no. 889 (1993): 19. http://dx.doi.org/10.2165/00128413-199308890-00045.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
13

Mishra, Chitaranjan, Usha Kim, and Mulasthanam Sai Dheera. "Combined Treatment Modality for Phthiriasis Palpebrarum." Indian Journal of Medical Microbiology 37, no. 2 (2019): 296–97. http://dx.doi.org/10.4103/ijmm.ijmm_19_251.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
14

Falkson, Geoffrey, Carla I. Falkson, and Conrad B. Falkson. "Combined modality treatment of gastrointestinal cancer." Current Opinion in Oncology 5, no. 4 (1993): 710–18. http://dx.doi.org/10.1097/00001622-199307000-00016.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
15

Ackerman, Ida, and Gillian M. Thomas. "Combined modality therapy for gynecologic cancer." Current Opinion in Oncology 7, no. 5 (1995): 466–72. http://dx.doi.org/10.1097/00001622-199509000-00013.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
16

Pisters, Peter W. T., and Brian O'Sullivan. "Retroperitoneal sarcomas: combined modality treatment approaches." Current Opinion in Oncology 14, no. 4 (2002): 400–405. http://dx.doi.org/10.1097/00001622-200207000-00006.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
17

Tordiglione, Michele, Maurizio Kalli, Vittorio Vavassori, and Roberto Luraghi. "Combined Modality Treatment for Esophageal Cancer." Tumori Journal 84, no. 2 (1998): 252–58. http://dx.doi.org/10.1177/030089169808400226.

Pełny tekst źródła
Streszczenie:
We have performed a review of recent literature about combined modality therapy in esophageal cancer. Radiobiological principles and radio-chemotherapy interactions modalities in clinical experiences have been considered. Therapeutic schedules, modalities of implementation, and the most relevant clinical results obtained by the major clinical research groups have been emphasized. We also comment on the current role of surgery and on the clinical questions arising in combined radio-chemotherapy treatment.
Style APA, Harvard, Vancouver, ISO itp.
18

Tilgen, W., U. Zierott, U. Keilholz, G. Longère, C. Scheibenbogen, and D. Petzoldt. "Combined modality therapy of metastatic melanoma." Melanoma Research 3, no. 1 (1993): 51. http://dx.doi.org/10.1097/00008390-199303000-00177.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
19

Sobat, H., A. Juretic, and M. Samija. "Combined modality therapy of rectal cancers." Annals of Oncology 10 (1999): S99—S104. http://dx.doi.org/10.1093/annonc/10.suppl_6.s99.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
20

Zhu, Andrew X., and Christopher G. Willett. "Combined modality treatment for rectal cancer." Seminars in Oncology 32, no. 1 (2005): 103–12. http://dx.doi.org/10.1053/j.seminoncol.2004.09.032.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
21

Tonlaar, Nathan, Suisui Song, Julian C. Hong, et al. "Combined-modality Therapy for Rectal Cancer." American Journal of Clinical Oncology 37, no. 2 (2014): 122–25. http://dx.doi.org/10.1097/coc.0b013e318271ae2c.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
22

Maughan, T. S., and T. D. L. Crosby. "Combined modality treatment in oesophageal carcinoma." Clinical Oncology 10, no. 6 (1998): 354–55. http://dx.doi.org/10.1016/s0936-6555(98)80028-9.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
23

Bodey, Rachel K., Phil M. Evans, and Glenn D. Flux. "Spatial aspects of combined modality radiotherapy." Radiotherapy and Oncology 77, no. 3 (2005): 301–9. http://dx.doi.org/10.1016/j.radonc.2005.10.006.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
24

Vokes, Everett E. "Combined modality therapy of solid tumours." Lancet 349 (May 1997): S4—S6. http://dx.doi.org/10.1016/s0140-6736(97)90011-8.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
25

Chamberlain, Marc C. "Combined-modality Treatment of Leptomeningeal Gliomatosis." Neurosurgery 52, no. 2 (2003): 324–30. http://dx.doi.org/10.1227/01.neu.0000043929.31608.62.

Pełny tekst źródła
Streszczenie:
Abstract OBJECTIVE Leptomeningeal gliomatosis (LG) is a clinically uncommon metastatic complication of high-grade gliomas (HGGs), for which there is no consensus regarding treatment. The goal of this study was to determine the toxicity and response rate of combined-modality therapy for the treatment of patients with HGGs and LG. METHODS Eighteen patients (10 men and 8 women), ranging in age from 28 to 70 years (median, 38 yr), with clinically, neuroradiologically, and cytologically documented LG received intraventricular chemotherapy. Tumor histological types included anaplastic astrocytoma (1
Style APA, Harvard, Vancouver, ISO itp.
26

Karpeh, Martin S., and David P. Kelsen. "Combined Modality Therapy of Gastric Cancer." Surgical Oncology Clinics of North America 6, no. 4 (1997): 741–47. http://dx.doi.org/10.1016/s1055-3207(18)30301-6.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
27

Blanke, Charles D., Hak Choy, and Steven D. Leach. "Combined modality therapy for esophageal cancer." Seminars in Radiation Oncology 7, no. 3 (1997): 15–23. http://dx.doi.org/10.1016/s1053-4296(97)80056-2.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
28

Sause, Willam T. "Combined modality therapy for lung cancer." Lung Cancer 18 (August 1997): 77–78. http://dx.doi.org/10.1016/s0169-5002(97)83906-2.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
29

Dottino, P. R., C. M. Johnston, A. M. Beddoe, J. Mandelli, and C. J. Cohen. "Combined modality treatment in cervical cancer." Gynecologic Oncology 40, no. 2 (1991): 191. http://dx.doi.org/10.1016/0090-8258(91)90212-n.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
30

Gamliel, Ziv, and Mark J. Krasna. "Combined modality therapy for esophageal cancer." Current Oncology Reports 1, no. 2 (1999): 149–54. http://dx.doi.org/10.1007/s11912-999-0026-2.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
31

MINSKY, B. "Combined modality therapy for esophageal cancer." Seminars in Oncology 30 (August 2003): 46–55. http://dx.doi.org/10.1016/s0093-7754(03)00272-0.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
32

TSAI, J. "Combined modality therapy for pancreatic cancer." Seminars in Oncology 30 (August 2003): 71–79. http://dx.doi.org/10.1016/s0093-7754(03)00273-2.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
33

Lombardi, Lucia, Michele Troiano, Nicola Silvestris, et al. "Combined modality treatments in pancreatic cancer." Expert Opinion on Therapeutic Targets 16, sup2 (2012): S71—S81. http://dx.doi.org/10.1517/14728222.2012.662959.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
34

Gibson, Michael K., and Arlene A. Forastiere. "Combined-Modality Therapy for Esophageal Cancer." Cancer Journal 9, no. 4 (2003): 238–40. http://dx.doi.org/10.1097/00130404-200307000-00003.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
35

Roelofsen, F., and H. Bartelink. "Combined Modality Treatment of Anal Carcinoma." Oncologist 3, no. 6 (1998): 413–18. http://dx.doi.org/10.1634/theoncologist.3-6-413.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
36

Baglan, R. J. "Combined modality therapy for lung cancer." Journal of Clinical Oncology 16, no. 2 (1998): 807–8. http://dx.doi.org/10.1200/jco.1998.16.2.807.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
37

Baumann, M., T. Herrmann, and H. D. Thames. "Combined modality in advanced Hodgkin's disease." Journal of Clinical Oncology 16, no. 8 (1998): 2893–94. http://dx.doi.org/10.1200/jco.1998.16.8.2893.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
38

Callery, Mark P. "Combined modality therapy for rectal cancer." Gastroenterology 128, no. 5 (2005): 1516–17. http://dx.doi.org/10.1053/j.gastro.2005.03.069.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
39

Einhorn, L. H. "Combined modality therapy in esophageal cancer." Journal of Clinical Oncology 8, no. 7 (1990): 1286–87. http://dx.doi.org/10.1200/jco.1990.8.7.1286.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
40

Patel, Sagar A., David P. Ryan, and Theodore S. Hong. "Combined Modality Therapy for Rectal Cancer." Cancer Journal 22, no. 3 (2016): 211–17. http://dx.doi.org/10.1097/ppo.0000000000000193.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
41

Klimm, Beate, and Andreas Engert. "Combined Modality Treatment of Hodgkin’s Lymphoma." Cancer Journal 15, no. 2 (2009): 143–49. http://dx.doi.org/10.1097/ppo.0b013e31819e31ba.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
42

Minsky, Bruce D., Claus Röedel, and Vincenzo Valentini. "Combined Modality Therapy for Rectal Cancer." Cancer Journal 16, no. 3 (2010): 253–61. http://dx.doi.org/10.1097/ppo.0b013e3181e0761c.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
43

Halberg, F., W. Warm, L. Fippin, et al. "Medulloblastoma: Results with combined modality therapy." International Journal of Radiation Oncology*Biology*Physics 17 (January 1989): 136. http://dx.doi.org/10.1016/0360-3016(89)90671-8.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
44

Fraunholz, Ingeborg, Daniela Rabeneck, Christian Weiß, and Claus Rödel. "Combined-Modality Treatment for Anal Cancer." Strahlentherapie und Onkologie 186, no. 7 (2010): 361–66. http://dx.doi.org/10.1007/s00066-010-2162-x.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
45

Raut, Chandrajit P., and Peter W. T. Pisters. "Retroperitoneal sarcomas: Combined-modality treatment approaches." Journal of Surgical Oncology 94, no. 1 (2006): 81–87. http://dx.doi.org/10.1002/jso.20543.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
46

Raghavan, Derek. "Combined modality treatment of bladder cancer." International Journal of Radiation Oncology*Biology*Physics 19 (January 1990): 103. http://dx.doi.org/10.1016/0360-3016(90)90613-o.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
47

Yao, James C., Paul F. Mansfield, Peter W. T. Pisters, et al. "Combined-modality therapy for gastric cancer." Seminars in Surgical Oncology 21, no. 4 (2003): 223–27. http://dx.doi.org/10.1002/ssu.10040.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
48

THIELECKE, HAYO. "Control effects as a modality." Journal of Functional Programming 19, no. 1 (2009): 17–26. http://dx.doi.org/10.1017/s0956796808006734.

Pełny tekst źródła
Streszczenie:
AbstractWe combine ideas from types for continuations, effect systems and monads in a very simple setting by defining a version of classical propositional logic in which double-negation elimination is combined with a modality. The modality corresponds to control effects, and it includes a form of effect masking. Erasing the modality from formulas gives classical logic. On the other hand, the logic is conservative over intuitionistic logic.
Style APA, Harvard, Vancouver, ISO itp.
49

Pauwels, Bea, Annelies E. C. Korst, Filip Lardon, and Jan B. Vermorken. "Combined Modality Therapy of Gemcitabine and Radiation." Oncologist 10, no. 1 (2005): 34–51. http://dx.doi.org/10.1634/theoncologist.10-1-34.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
50

Thomas, Charles Richard. "Interview: Combined-modality therapy in gastrointestinal cancers." Colorectal Cancer 2, no. 1 (2013): 27–30. http://dx.doi.org/10.2217/crc.13.1.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
Oferujemy zniżki na wszystkie plany premium dla autorów, których prace zostały uwzględnione w tematycznych zestawieniach literatury. Skontaktuj się z nami, aby uzyskać unikalny kod promocyjny!